Shu-Hui Yen

6.6k citations

58 papers · 5.0k indexed · 2 hit papers · h-index 35

Physiology top 0.5%
Molecular Biology top 5%
Neurology top 0.5%
Cellular and Molecular Neuroscience top 1%
Neurology top 0.5%

Co-authors: Dennis W. Dickson Peizhou Jiang Jada Lewis Peter Davies Parimala Nacharaju Li‐wen Ko Daniel Sevlever Michael Hutton
Topics: Alzheimer's disease research and treatments (41 papers)Parkinson's Disease Mechanisms and Treatments (22 papers)Neuroscience and Neuropharmacology Research (10 papers)
Cited by: Neurology Physiology
Journals: Science Journal of Biological Chemistry Neuron
Partner nations: United States Japan United Kingdom

In The Last Decade

Shu-Hui Yen

58 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

2000 1.0k citations Jada Lewis, Eileen McGowan et al. profile →
Identification of normal and pathological aging in prospectively studied nondemented elderly humans

1992 502 citations Dennis W. Dickson, Shu-Hui Yen et al. profile →

Peers

Countries citing papers authored by Shu-Hui Yen

Since Specialization

Citations

This map shows the geographic impact of Shu-Hui Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Hui Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Hui Yen more than expected).

Fields of papers citing papers by Shu-Hui Yen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Hui Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Hui Yen. The network helps show where Shu-Hui Yen may publish in the future.

Co-authorship network of co-authors of Shu-Hui Yen

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Hui Yen. A scholar is included among the top collaborators of Shu-Hui Yen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Hui Yen. Shu-Hui Yen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired endo-lysosomal membrane integrity accelerates the seeding progression of α-synuclein aggregates 2017 ·Scientific Reports ·Peizhou Jiang,Ming Gan,Shu-Hui Yen,Pamela J. McLean,Dennis W. Dickson	78
2	Genetic modification of H2AX renders mesenchymal stromal cell–derived dopamine neurons more resistant to DNA damage and subsequent apoptosis 2016 ·Cytotherapy ·Peizhou Jiang,Peng Huang,Shu-Hui Yen,Abba C. Zubair,Dennis W. Dickson	7
3	Dopamine prevents lipid peroxidation-induced accumulation of toxic α-synuclein oligomers by preserving autophagy-lysosomal function 2013 ·Frontiers in Cellular Neuroscience ·Peizhou Jiang,Ming Gan,Shu-Hui Yen	17
4	ER stress response plays an important role in aggregation of α-synuclein 2010 ·Molecular Neurodegeneration ·Peizhou Jiang,Ming Gan,Abdul Shukkur Ebrahim,Wen-Lang Lin,Heather L. Melrose,Shu-Hui Yen	93
5	Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments 2010 ·Molecular Neurodegeneration ·Yong‐Jie Zhang,Tania F. Gendron,Ya-Fei Xu,Li‐wen Ko,Shu-Hui Yen,Leonard Petrucelli	104
6	Reduced expression of peroxisome-proliferator activated receptor gamma coactivator-1α enhances α-synuclein oligomerization and down regulates AKT/GSK3β signaling pathway in human neuronal cells that inducibly express α-synuclein 2010 ·Neuroscience Letters ·Abdul Shukkur Ebrahim,Li‐wen Ko,Shu-Hui Yen	29
7	Aggregates Assembled From Overexpression of Wild-Type α-Synuclein are not Toxic to Human Neuronal Cells 2008 ·Journal of Neuropathology & Experimental Neurology ·Li‐wen Ko,(unknown),Wen-Lang Lin,(unknown),Shu-Hui Yen	38
8	Cytosine β-D-arabinofuranoside used as a Paradigm Modifier to Increase Production of Tau Aggregates in a Cellular Model of Tauopathy 2006 ·Neurochemical Research ·Li‐wen Ko,(unknown),Shu-Hui Yen	2
9	Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau 2005 ·Journal of Biological Chemistry ·Kiran Bhaskar,Shu-Hui Yen,Gloria Lee	187
10	Recent advances in experimental modeling of the assembly of tau filaments 2004 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Li‐wen Ko,Michael DeTure,Naruhiko Sahara,(unknown),Irving E. Vega,Shu-Hui Yen	16
11	Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau 2003 ·Journal of Neurocytology ·Wen-Lang Lin,Jada Lewis,Shu-Hui Yen,Michael Hutton,Dennis W. Dickson	108
12	Co-Localization of Glycogen Synthase Kinase-3 with Neurofibrillary Tangles and Granulovacuolar Degeneration in Transgenic Mice 2003 ·American Journal Of Pathology ·Takashi Ishizawa,(unknown),Koichi Ishiguro,(unknown),Eileen McGowan,Jada Lewis,Michael Hutton,Dennis W. Dickson,Shu-Hui Yen	77
13	Effects on splicing and protein function of three mutations in codon N296 of tau in vitro 2002 ·Neuroscience Letters ·Andrew Grover,Michael DeTure,Shu-Hui Yen,Mike Hutton	39
14	Cellular Models for Tau Filament Assembly 2002 ·Journal of Molecular Neuroscience ·Li‐wen Ko,Michael DeTure,Naruhiko Sahara,(unknown),Shu-Hui Yen	13
15	tau Assembly in Inducible Transfectants Expressing Wild-Type or FTDP-17 tau 2002 ·American Journal Of Pathology ·Michael DeTure,Li‐wen Ko,Colin Easson,Shu-Hui Yen	59
16	Accelerated filament formation from tau protein with specific FTDP‐17 missense mutations 1999 ·FEBS Letters ·Parimala Nacharaju,Jada Lewis,Colin Easson,(unknown),(unknown),(unknown),Mike Hutton,Shu-Hui Yen	237
17	Ser‐262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK 1998 ·FEBS Letters ·Juan Sironi,Shu-Hui Yen,(unknown),Qiongli Wu,Inge Grundke‐Iqbal,Khalid Iqbal	68
18	Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells 1997 ·Brain Research ·Li‐wen Ko,Toshinari Odawara,Shu-Hui Yen	24
19	Modulated induction of tau proteins in cultured human neuroblastoma cells 1996 ·Brain Research ·Li‐wen Ko,(unknown),Irene S. Georgieff,Shu-Hui Yen	7
20	Structural stability of paired helical filaments requires microtubule-binding domains of Tau: A model for self-association 1991 ·Neuron ·Hanna Ksiȩżak-Reding,Shu-Hui Yen	117

About Shu-Hui Yen

Shu-Hui Yen is a scholar working on Neurology, Physiology and Neurology, having authored 58 papers that have together received 5.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (41 papers), Parkinson's Disease Mechanisms and Treatments (22 papers) and Neuroscience and Neuropharmacology Research (10 papers). The work is most often cited by research in Neurology (1.1k citations), Physiology (3.4k citations) and Neurology (1.5k citations). Shu-Hui Yen has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Dennis W. Dickson, Peizhou Jiang, Jada Lewis, Peter Davies, Parimala Nacharaju, Li‐wen Ko, Daniel Sevlever, Michael Hutton, Wen-Lang Lin and Ágnes Kenessey. Their work appears in journals such as Science, Journal of Biological Chemistry and Neuron.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact